| The Iodine Group | ||
|
Home | Orthoiodosupplementation | Body | Disease | Special | Overviews |
||
|
|
Abraham
The historical background of the iodine project.Abraham GE The Original Internist, 12(2):57-66, 2005
"Amiodarone is a toxic form of sustained release iodine. The author has previously discussed the interesting observation that this antiarrhythmic drug becomes effective when the body has accumulated approximately 1.5 gm of iodine. This is exactly the amount of iodine retained by the human body when iodine sufficiency is achieved following orthoiodosupplementation. Whole body sufficiency for inorganic non-radioactive iodine/iodide results in optimal cardiac functions. Inorganic non-radioactive iodine was never tested in clinical conditions for which physicians prescribe amiodarone. However, inorganic iodide is blamed for the severe side effects of this drug."
|
|
Home | Orthoiodosupplementation | Body | Disease | Special Topics | OverviewsThe Iodine Group | Books | Disclaimers | Contact Us | SearchCopyright: Zoe, 2006. |
||